false
OasisLMS
Catalog
SCCM Resource Library
Year in Review: Neuroscience: Pharmacology Researc ...
Year in Review: Neuroscience: Pharmacology Research Update 2
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The presentation discussed several significant studies from 2023 in neurocritical care medicine, focusing on their findings and limitations. The BEST-2 and Optimal BP trials examined blood pressure management after mechanical thrombectomy for ischemic stroke, finding no clear benefit or harm from lower systolic blood pressure targets. The INTERACT-3 trial explored a bundled care approach for intracerebral hemorrhage, showing potential improvement in outcomes with early aggressive treatment. The Early Drain trial indicated that adding a lumbar drain to standard care in subarachnoid hemorrhage patients might reduce unfavorable outcomes. Lastly, the RESCUE-ASDH study compared craniotomy and craniectomy for acute subdural hematoma, finding no significant differences in primary outcomes but noting variations in secondary outcomes, like wound infections and additional surgeries. Limitations included issues like data generalizability, patient condition disparities, and intervention timing across these studies.
Asset Caption
Year in Review | Year in Review: Neuroscience
Meta Tag
Content Type
Presentation
Membership Level
Professional
Membership Level
Select
Year
2024
Keywords
neurocritical care
ischemic stroke
intracerebral hemorrhage
subarachnoid hemorrhage
acute subdural hematoma
clinical trials 2023
×
Please select your language
1
English